MORRETTA, Elva
 Distribuzione geografica
Continente #
AS - Asia 3.147
NA - Nord America 617
EU - Europa 317
SA - Sud America 76
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.166
Nazione #
HK - Hong Kong 2.896
US - Stati Uniti d'America 605
SG - Singapore 116
RU - Federazione Russa 100
IT - Italia 93
CN - Cina 70
BR - Brasile 66
DE - Germania 34
IE - Irlanda 27
IN - India 18
VN - Vietnam 14
FI - Finlandia 11
KR - Corea 11
AT - Austria 10
SE - Svezia 10
AR - Argentina 7
PL - Polonia 6
TR - Turchia 5
CA - Canada 4
GB - Regno Unito 4
LT - Lituania 4
MX - Messico 4
ZA - Sudafrica 4
BD - Bangladesh 3
UA - Ucraina 3
UZ - Uzbekistan 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
FR - Francia 2
ID - Indonesia 2
LU - Lussemburgo 2
TJ - Tagikistan 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
IQ - Iraq 1
JP - Giappone 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.166
Città #
Hong Kong 2.893
Chandler 123
Dallas 105
Singapore 59
Princeton 55
Ashburn 48
Ann Arbor 30
Dublin 23
Moscow 21
Beijing 17
Salerno 15
Nuremberg 13
Los Angeles 11
Munich 11
Wilmington 10
Naples 9
Santa Clara 9
Andover 7
Pune 7
The Dalles 7
Warsaw 7
Fairfield 6
Jacksonville 6
New York 6
Seattle 6
São Paulo 6
Vienna 6
Boardman 5
Ho Chi Minh City 5
Verona 5
Washington 5
Brooklyn 4
Chennai 4
Fisciano 4
Hanoi 4
Johannesburg 4
Milan 4
Sarno 4
Stockholm 4
Turku 4
Brescia 3
Carbonia 3
Central 3
Columbus 3
Denver 3
Helsinki 3
Lappeenranta 3
Napoli 3
Tashkent 3
Uberlândia 3
Ansbach 2
Assago 2
Avellino 2
Brno 2
Brussels 2
Calgary 2
Cambridge 2
Campinas 2
Chicago 2
Curitiba 2
Dushanbe 2
Esslingen am Neckar 2
Foggia 2
Guangzhou 2
Guarulhos 2
Hefei 2
Houston 2
Innsbruck 2
Jakarta 2
Jiaxing 2
Luxembourg 2
Menlo Park 2
Mugnano di Napoli 2
Mumbai 2
Redwood City 2
Ribeirão Preto 2
Rome 2
Santo Domingo Este 2
Shanghai 2
Shenyang 2
Sumaré 2
Vilnius 2
Abdon Batista 1
Ankara 1
Anyang 1
Aparecida de Goiânia 1
Araucária 1
Araçatuba 1
Araçuaí 1
Asunción 1
Atlanta 1
Augusta 1
Baghdad 1
Baku 1
Bangkok 1
Banská Bystrica 1
Belo Horizonte 1
Belém 1
Betim 1
Bogotá 1
Totale 3.684
Nome #
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 987
Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid 582
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 314
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics 288
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 209
H3K56 acetylation affects Candida albicans morphology and secreted soluble factors interacting with the host 168
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 140
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 135
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 104
Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches 97
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 97
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 88
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 88
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 88
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative 72
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 71
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 68
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 66
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 66
Label-Free Quantitative Proteomics to Explore the Action Mechanism of the Pharmaceutical-Grade Triticum vulgare Extract in Speeding up Keratinocyte Healing 63
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 61
Identification of Mortalin as the Main Interactor of Mycalin A, a Poly-Brominated C-15 Acetogenin Sponge Metabolite, by MS-Based Proteomics 56
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 56
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 52
Carbamoyl-phosphate synthase 1 as a novel target of phomoxanthone a, a bioactive fungal metabolite 51
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 50
The pyrazolyl-urea gege3 inhibits the activity of ANXA1 in the angiogenesis induced by the pancreatic cancer derived EVs 38
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 37
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 33
Totale 4.225
Categoria #
all - tutte 11.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 3 1 3 6 1 2 2 8 8
2021/2022125 1 0 6 4 4 2 5 18 9 24 10 42
2022/2023254 19 30 11 30 27 56 1 18 27 5 22 8
2023/2024165 10 16 17 11 16 24 17 11 2 7 9 25
2024/2025441 5 8 6 13 20 49 123 22 36 19 56 84
2025/20263.156 731 1.388 976 61 0 0 0 0 0 0 0 0
Totale 4.225